Linfeng Xu

680 total citations
24 papers, 251 citations indexed

About

Linfeng Xu is a scholar working on Hepatology, Surgery and Molecular Biology. According to data from OpenAlex, Linfeng Xu has authored 24 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 8 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Linfeng Xu's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Cancer Mechanisms and Therapy (4 papers). Linfeng Xu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Cancer Mechanisms and Therapy (4 papers). Linfeng Xu collaborates with scholars based in China and United States. Linfeng Xu's co-authors include Jiayan Ni, Hongliang Sun, Jianghong Luo, Weidong Wang, Shanshan Liu, Xiongying Jiang, Jingxing Zhou, Binhui Xie, Heping Li and Weihao Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and The Plant Journal.

In The Last Decade

Linfeng Xu

20 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linfeng Xu China 10 128 73 64 63 57 24 251
Cheng‐Qian Zhong China 9 139 1.1× 95 1.3× 77 1.2× 71 1.1× 36 0.6× 20 277
Yichuan Yuan China 8 135 1.1× 82 1.1× 70 1.1× 58 0.9× 62 1.1× 20 265
Ningyuan Wen China 7 110 0.9× 71 1.0× 66 1.0× 50 0.8× 63 1.1× 22 241
Renfeng Shan China 12 90 0.7× 122 1.7× 116 1.8× 39 0.6× 56 1.0× 27 297
Loretta D’Onofrio Italy 8 93 0.7× 60 0.8× 77 1.2× 46 0.7× 80 1.4× 18 299
Maria Aurelia Barbera Italy 9 104 0.8× 69 0.9× 53 0.8× 60 1.0× 70 1.2× 19 284
Yanfu Sun China 10 144 1.1× 87 1.2× 61 1.0× 81 1.3× 121 2.1× 15 367
Satoshi Moriya Japan 11 193 1.5× 42 0.6× 46 0.7× 141 2.2× 33 0.6× 31 305
Yutaro Mihara Japan 9 77 0.6× 55 0.8× 44 0.7× 61 1.0× 28 0.5× 30 236

Countries citing papers authored by Linfeng Xu

Since Specialization
Citations

This map shows the geographic impact of Linfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linfeng Xu more than expected).

Fields of papers citing papers by Linfeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linfeng Xu. The network helps show where Linfeng Xu may publish in the future.

Co-authorship network of co-authors of Linfeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Linfeng Xu. A scholar is included among the top collaborators of Linfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linfeng Xu. Linfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Jiawei, Yifan Kong, Dongrui R. Lu, et al.. (2025). Explainable machine learning model for predicting the transarterial chemoembolization response and subtypes of hepatocellular carcinoma patients. BMC Gastroenterology. 25(1). 503–503.
3.
4.
Xu, Yu, et al.. (2023). Evolutionary analysis of conserved non‐coding elements subsequent to whole‐genome duplication in opium poppy. The Plant Journal. 116(6). 1804–1824. 1 indexed citations
5.
6.
Wang, Weidong, et al.. (2020). Effectiveness and safety of irreversible electroporation for recurrent hepatocellular carcinoma ineligible for thermal ablation after surgery. SHILAP Revista de lepidopterología. 3(3). 151–155. 5 indexed citations
7.
Kong, Jian, Xiongying Jiang, Yanfang Zhang, et al.. (2020). Clinical management of vascular lake during transarterial chemoembolization with CalliSpheres drug-eluting beads (DEBs) for the treatment of hepatocellular carcinoma. Translational Cancer Research. 9(4). 2895–2903. 10 indexed citations
8.
Wang, Weidong, et al.. (2019). Nucleolar spindle associated protein 1 (NUSAP1) facilitates proliferation of hepatocellular carcinoma cells. Translational Cancer Research. 8(5). 2113–2120. 9 indexed citations
9.
Wang, Yu, Binhui Xie, Weihao Lin, et al.. (2019). Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2. Oncogene. 38(25). 4948–4961. 54 indexed citations
10.
Wang, Weidong, Lihua Zhang, Jiayan Ni, et al.. (2018). Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis. Korean Journal of Radiology. 19(4). 613–613. 14 indexed citations
11.
Ni, Jiayan, Jian Kong, Hongliang Sun, et al.. (2017). Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas. Academic Radiology. 25(4). 423–429. 10 indexed citations
12.
Ni, Jiayan, Hongliang Sun, Jianghong Luo, et al.. (2017). Drug-eluting bead transarterial chemoembolization in the treatment for unresectable soft tissue sarcoma refractory to systemic chemotherapy: a preliminary evaluation of efficacy and safety. Journal of Cancer Research and Clinical Oncology. 144(1). 157–163. 13 indexed citations
13.
Sun, Hongliang, et al.. (2017). The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT. OncoTargets and Therapy. Volume 10. 3835–3842. 7 indexed citations
14.
Ni, Jiayan, et al.. (2016). Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model. Journal of Cancer Research and Clinical Oncology. 143(2). 199–207. 9 indexed citations
15.
Li, Huiqing, Xiongying Jiang, Dong Chen, et al.. (2016). Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study. European Radiology. 26(10). 3500–3509. 3 indexed citations
16.
Chen, Wei‐liang, Linfeng Xu, Qiong-Lan Tang, & Daming Zhang. (2015). Management of Carotid Body Tumor and Pseudoaneurysm After Blunt Dissection. Journal of Craniofacial Surgery. 26(2). 477–480. 6 indexed citations
17.
Xu, Jixiong, et al.. (2015). IGFBP-3 A-202C and C2133G polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies. Genetics and Molecular Research. 14(2). 3370–3386. 1 indexed citations
18.
Ni, Jiayan, et al.. (2013). Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients. Journal of Cancer Research and Clinical Oncology. 139(12). 2021–2033. 33 indexed citations
19.
Xu, Linfeng. (2013). Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells. World Journal of Gastroenterology. 19(11). 1749–1749. 17 indexed citations
20.
Ni, Jiayan, et al.. (2013). Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis. Journal of Cancer Research and Clinical Oncology. 139(4). 653–659. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng‐Qian Zhong Breakdown of academic impact, for papers by Yichuan Yuan Breakdown of academic impact, for papers by Ningyuan Wen Breakdown of academic impact, for papers by Renfeng Shan Breakdown of academic impact, for papers by Loretta D’Onofrio Breakdown of academic impact, for papers by Maria Aurelia Barbera Breakdown of academic impact, for papers by Yanfu Sun Breakdown of academic impact, for papers by Satoshi Moriya Breakdown of academic impact, for papers by Yutaro Mihara
Rankless by CCL
2026